본문 바로가기
KERD
논문KCI 등재

단일 상급종합병원에서 노인 환자의 다제약물 복약상담 현황

Current Status of Polypharmacy Counseling for Elderly Patients in a Tertiary Hospital

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Background : Elderly patients have a high rate of polypharmacy due to the increased prevalence of chronic diseases. Polypharmacy can increase the risk of poor drug compliance, drug-related problems (DRPs), and potentially inappropriate medication (PIM) use. Therefore, the purpose of this study was to present a direction to improve polypharmacy management for the elderly by analyzing the status and results of polypharmacy counseling for the elderly. Methods : A retrospective medical record review study was conducted from September 2021 to August 2022 based on the polypharmacy counseling records at a tertiary hospital. DRPs were analyzed using Pharmaceutical Care Network Europe (PCNE) Classification version 9.1. PIMs were compared before and after polypharmacy counseling using the screening tools for older person’s potentially inappropriate prescriptions (STOPP). Results : The median age of the 46 included patients was 80.5. The median number of drugs administered was 16. The median number of DRPs was two, and 63% of the patients were using PIMs based on STOPP. Among 115 cases of DRPs, ‘adverse drug event (possibly) occurring’ accounted for the most (68.7%). Among the causes of 124 DRPs, ‘drug selection’ accounted for the most (71.8%). The 378 interventions were in the order of the patient level’ (48.4%), the prescriber level’ (30.4%), and the drug level’ (21.2%), and the intervention acceptance rate was 87.8%. After counseling, 86.9% of the DRPs were completely or partially resolved. PIMs based on STOPP decreased from 45 to 39 cases. In particular, the unnecessary use of proton pump inhibitors (PPIs) decreased the most. Conclusion : Most DRPs and PIMs were resolved through various interventions by pharmacists. The pharmacist’s role in continuously monitoring medications for elderly patients after polypharmacy counseling is important and should be expanded further.

Abstract

Background : Elderly patients have a high rate of polypharmacy due to the increased prevalence of chronic diseases. Polypharmacy can increase the risk of poor drug compliance, drug-related problems (DRPs), and potentially inappropriate medication (PIM) use. Therefore, the purpose of this study was to present a direction to improve polypharmacy management for the elderly by analyzing the status and results of polypharmacy counseling for the elderly. Methods : A retrospective medical record review study was conducted from September 2021 to August 2022 based on the polypharmacy counseling records at a tertiary hospital. DRPs were analyzed using Pharmaceutical Care Network Europe (PCNE) Classification version 9.1. PIMs were compared before and after polypharmacy counseling using the screening tools for older person’s potentially inappropriate prescriptions (STOPP). Results : The median age of the 46 included patients was 80.5. The median number of drugs administered was 16. The median number of DRPs was two, and 63% of the patients were using PIMs based on STOPP. Among 115 cases of DRPs, ‘adverse drug event (possibly) occurring’ accounted for the most (68.7%). Among the causes of 124 DRPs, ‘drug selection’ accounted for the most (71.8%). The 378 interventions were in the order of the patient level’ (48.4%), the prescriber level’ (30.4%), and the drug level’ (21.2%), and the intervention acceptance rate was 87.8%. After counseling, 86.9% of the DRPs were completely or partially resolved. PIMs based on STOPP decreased from 45 to 39 cases. In particular, the unnecessary use of proton pump inhibitors (PPIs) decreased the most. Conclusion : Most DRPs and PIMs were resolved through various interventions by pharmacists. The pharmacist’s role in continuously monitoring medications for elderly patients after polypharmacy counseling is important and should be expanded further.

참고문헌 (14)

  1. "Medication Safety in Polypharmacy Technical Report" (2019)[URL]
  2. Herr M, "Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people", Pharmacoepidemiol Drug Saf, 24(6), pp.637~646 (2015)
  3. Haliu B, "Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions", BMC Geriatrics, 20(1), pp.13~ (2020)
  4. Kim HA, "Prevalence and predictors of polypharmacy among Korean elderly", PLoS One, 9(6), pp.e98043~ (2014)
  5. 박혜영, "우리나라의 다제약제 현황과 적정관리 방안에 대한 고찰", 한국임상약학회지, 28(1), pp.1~9 (2018), 한국임상약학회[DOI]
  6. "Classification for drug related problems V9.1" (2020)[URL]
  7. 노인의 다약제 사용관리방안, "김동숙", 1~387, pp.연구보고서. 2022(6) (2022)
  8. 국민건강보험공단, "다제약물 관리사업 병원모형(2차) 업무 매뉴얼(의료기관용)", 1~35 (2021)
  9. "만성질환(11종) 현황", 국가통계포털(KOSIS)[URL]
  10. Rockwood K, "A global clinical measure of fitness and frailty in elderly people", CMAJ, 173(5), pp.489~495 (2005)
  11. Jun K, "Development of an anticholinergic burden scale specific for Korean older adults", Geriatrics & gerontology international, 19(7), pp.628~634 (2019)
  12. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel, "American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults", J Am Geriatr Soc, 67(4), pp.674~694 (2019)
  13. O’Mahony D, "STOPP", START criteria for potentially inappropriate prescribing in older people: version 2, 2015, pp.44(2), 213~218
  14. Desilets AR, "Considerations for the use of protonpump inhibitors in older adults", Consult Pharm, 27(2), pp.114~120 (2012)

관련 논문AI추천

이 간행물의 다른 논문 (4건)